ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations

Effects of estrogen receptorβ (ERβ) localization on epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in advanced non-small cell lung cancer (NSCLC) are unknown. First, we analyzed the relationship between ERβ localization determined by immunohistochemistry and EGFR-TKI outcome...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Sci Rep
Glavni autori: Wang, Zhijie, Li, Zhenxiang, Ding, Xiaosheng, Shen, Zhirong, Liu, Zhentao, An, Tongtong, Duan, Jianchun, Zhong, Jia, Wu, Meina, Zhao, Jun, Zhuo, Minglei, Wang, Yuyan, Wang, Shuhang, Sun, Yu, Bai, Hua, Wang, Jie
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4476037/
https://ncbi.nlm.nih.gov/pubmed/26096604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep11392
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items